Nucleic Acid Isolation and Purification Market

Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, mRNA), Application (Diagnostics, Personalized Medicine), End User (CROs) & Region - Global Forecast to 2028

Report Code: BT 2398 Oct, 2023, by marketsandmarkets.com

The global nucleic acid isolation and purification market in terms of revenue was estimated to be worth $6.4 billion in 2023 and is poised to reach $9.4 billion by 2028, growing at a CAGR of 8.1% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Factors responsible for the growth of this market include growing research and development activities, advancements in technologies, and growing automation.

Attractive Opportunities in the Nucleic Acid Isolation and Purification Market

Nucleic Acid Isolation and Purification  Market

To know about the assumptions considered for the study, Request for Free Sample Report

Nucleic Acid Isolation and Purification  Market

Global NAIP Market Dynamics

DRIVER: Growing demand for molecular diagnostics

Nucleic acid isolation and purification is a critical step in many molecular diagnostic tests, such as those used to detect infectious diseases, genetic disorders, and cancer. The increasing demand for molecular diagnostics is driven by several factors, including the rising prevalence of chronic diseases, the growing awareness of the importance of personalized medicine, the development of new molecular diagnostic tests, and the increasing availability of molecular diagnostic testing. Some specific examples of how molecular diagnostics is used to improve healthcare include cancer diagnosis and treatment, infectious disease diagnosis and treatment, and genetic testing. Overall, the increasing demand for molecular diagnostics is a positive trend for healthcare. Molecular diagnostics helps to improve the diagnosis and treatment of a wide range of diseases and conditions, which leads to better patient outcomes. As the demand for molecular diagnostics continues to grow, so will the demand for nucleic acid isolation and purification products.

RESTRAINT: High cost of automated instruments

The cost of automated instruments for NAIP instruments are associated with additional expenses for reagents, disposables, and maintenance and training. Institutes and companies with smaller R&D budgets cannot afford these expensive instruments. Academic research laboratories in emerging economies also find it difficult to invest in such systems, as they have controlled budgets. Hence, the penetration of these high-cost automated systems is likely to be lower in emerging economies, which impedes the growth of this market.

OPPORTUNITY: Growth opportunities in emerging economies

Emerging economies such as India, Brazil, Turkey, Russia, and South Africa are expected to offer potential growth opportunities for major players operating in this market. This can be attributed to the high disease prevalence, large patient population, improved healthcare infrastructure, increasing disposable income, and growing medical tourism. The North American and European markets for nucleic acid isolation and purification are expected to witness slower growth compared to the market in Asia. Asian countries, specifically China, Japan, and India, provide potential growth opportunities for the nucleic acid isolation and purification kits, reagents, and instruments market. These growth opportunities can mainly be attributed to the growing biopharmaceutical and biotechnology sectors and the development of bio clusters in these countries. This is further supported by the developing healthcare infrastructure and increasing healthcare expenditure. Also, with the large population and increasing need for affordable care, these markets offer significant growth opportunities for players. Advantages such as low manufacturing costs and customs duties attract major pharma and biotech companies to this region.

CHALLENGE: Introduction to alternate technologies

The rise of new technologies, such as microfluidics and digital PCR, is a major challenge for the nucleic acid isolation and purification market. These technologies can offer faster, more efficient, and more accurate ways to isolate and purify nucleic acids. Microfluidics is a technology that manipulates fluids at the microscale. Microfluidic devices can be used to create precise and reproducible fluid flows, which can be used to automate and accelerate the nucleic acid isolation and purification process. Digital PCR is a technology that uses microfluidics to partition a sample into millions of individual droplets. Each droplet contains a single copy of the target nucleic acid. This allows for more sensitive and accurate detection of nucleic acids than traditional PCR methods. In addition to the technologies mentioned above, there are several other new technologies that are emerging that could potentially disrupt the market. For example, researchers are developing new methods for isolating and purifying nucleic acids using nanoparticles and other nanomaterials. Additionally, researchers are developing new methods for isolating and purifying nucleic acids without the need for centrifugation.

Ecosystem of Nucleic Acid Isolation and Purification Market

Nucleic Acid Isolation and Purification  Market Ecosystem

The Kit Product type segment accounted for the largest share of global nucleic acid isolation and purification industry in 2022.

Based on products, the nucleic acid isolation and purification market has been segmented into kits, reagents, and instruments. The instruments segment is further segmented into automatic and manual instruments. In 2022, the kits segment accounted for the largest share of the global market. Factors responsible for the growth in this market include easy usage and the continuous focus of key market players on developing and launching advanced kits.

Plasmid DNA isolation and purification type segment of the nucleic acid isolation and purification industry expected to grow at a higher growth rate during the forecast period

Based on type, the global nucleic acid isolation and purification market is segmented into messenger RNA isolation and purification, circulating nucleic acid isolation and purification, plasmid DNA isolation and purification, genomic DNA isolation and purification, total RNA isolation and purification, microRNA isolation and purification, and other nucleic acid isolation and purification types. In 2022, the plasmid DNA isolation and purification segment accounted for the major share of the market and the segment is expected to grow at a higher rate during the forecast period due to wide usage of purified plasmid DNA in a variety of various downstream applications, and the increasing application in gene expression profiling.

Personalized medicine application segment of the nucleic acid isolation and purification industry expected to grow at a higher CAGR during the forecast period

Based on application, the global nucleic acid isolation and purification market is segmented into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications. In 2022, the diagnostics segment accounted ofr the largest share of the global market. However, the personalized medicine segment is anticipated to experience a higher growth rate in the forecast period due to the escalating demand for genomic data in diagnostic and treatment decision-making, along with ongoing advancements in genomic research. . These products play a crucial role in obtaining high-quality genetic material for personalized medical tests and therapies, driving their market growth.

The Asia Pacific is the fastest growing region for nucleic acid isolation and purification industry.

The nucleic acid isolation and purification market is broadly divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. During the forecast period, Asia Pacific is expected to grow the highest.

The Asia Pacific is the fastest growing and most dynamic market in the world and is estimated to be the most attractive regional market for NAIP. Countries such as China, India, and Japan are expected to witness high growth in the market for NAIP because of the large population in these countries. Also, due to rising health concerns, higher incomes, and better government initiatives, the pharmaceutical market in this region is projected to grow. Together, these factors fuel the growth of the NAIP market in the Asia Pacific region. The growing Asian scientific base and capability, growth in the Asian pharmaceutical market and pharmaceutical manufacturing capabilities, and the large patient pool in several Asia Pacific countries are driving the growth of this regional market. With its huge potential for growth and the low cost of manufacturing, several global pharmaceutical companies are establishing facilities or enhancing their existing facilities in the Asia Pacific.

Nucleic Acid Isolation and Purification  Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key players in the nucleic acid isolation and purification market are Thermo Fisher Scientific Inc. (US), QIAGEN (Germany), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Promega Corporation (US), Agilent Technologies, Inc. (US), Danaher (US), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Takara Bio Inc. (Japan), New England Biolabs (US), Abcam Plc (UK), KILPEST India Limited (India), Apical Scientific Sdn. Bhd. (Malaysia), Endress+Hauser Group Services AG (Switzerland), GENAXXON Bioscience GmbH (Germany), LGC Biosearch Technologies (US), Zymo Research Corporation (US), Norgen Biotek Corp. (Canada), Omega Bio-Tek, Inc. (US), FAVORGEN Biotech Corp. (China), TIANGEN Biotech (Beijing) Co., Ltd. (China), AutoGen Inc. (US), PCR Biosystems (UK), and Biogenuix (India).

Scope of the Nucleic Acid Isolation and Purification Industry

Report Metric

Details

Market Revenue in 2023

$6.4 billion

Projected Revenue by 2028

$9.4 billion

Revenue Rate

Poised to Grow at a CAGR of 8.1%

Market Driver

Growing demand for molecular diagnostics

Market Opportunity

Growth opportunities in emerging economies

This report categorizes the nucleic acid isolation and purification market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Kits
  • Reagents
  • Instruments
    • Manual
    • Automatic

By Type

  • Plasmid DNA Isolation and Purification
  • Total RNA Isolation and Purification
  • Circulating Nucleic Acid Isolation and Purification
  • Genomic DNA Isolation and Purification
  • Messenger RNA Isolation and Purification
  • microRNA Isolation and Purification
  • Other Nucleic Acid Isolation and Purification Types

By Method

  • Column-based Isolation and Purification
  • Magnetic Bead-based Isolation and Purification
  • Reagent-based Isolation and Purification
  • Other Isolation and Purification Methods

By Application

  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicine
  • Agriculture & Animal Research
  • Other Applications

By End User

  • Hospitals & Diagnostic Centers
  • Academic & Government Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East & Africa
    • Middle East
    • Africa

Recent Developments of Nucleic Acid Isolation and Purification Industry

  • In August 2023, Danaher Corporation entered into a definitive agreement to acquire all the outstanding shares of Abcam. Through this development, Abcam is expected to operate as a standalone operating company within Danaher’s Life Sciences segment.
  • In July 2023, INOVIQ and Promega announced a global joint marketing agreement for EXO-NET exosome isolation and nucleic acid purification solutions.
  • In May 2022, Thermo Fisher partnered with the Qatar Genome Program (QGP), a member of the Qatar Foundation (QF), to accelerate genomic research and clinical applications of predictive genomics in Qatar.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 44)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 STUDY SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY 
    1.5 LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
    1.8 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 50)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 3 MARKET: MARKET SIZE ESTIMATION FOR SUPPLY-SIDE ANALYSIS (2022)
          FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS) FOR 2022
          FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS FOR 2022
           2.2.1 PRIMARY INSIGHTS
                    FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
                    FIGURE 7 TOP-DOWN APPROACH
    2.3 MARKET GROWTH RATE PROJECTIONS 
          FIGURE 8 MARKET: CAGR PROJECTIONS FOR FORECAST PERIOD
          FIGURE 9 MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
    2.4 DATA TRIANGULATION APPROACH 
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.5 STUDY ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 RECESSION IMPACT ANALYSIS 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
          TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
          TABLE 3 US HEALTH EXPENDITURE, 2023–2028 (USD MILLION)
 
3 EXECUTIVE SUMMARY (Page No. - 63)
    FIGURE 11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT,  2023 VS. 2028 (USD MILLION)
    FIGURE 12 MARKET, BY METHOD,  2023 VS. 2028 (USD MILLION)
    FIGURE 13 MARKET, BY APPLICATION,  2023 VS. 2028 (USD MILLION)
    FIGURE 14 MARKET, BY TYPE,  2023 VS. 2028 (USD MILLION)
    FIGURE 15 MARKET, BY END USER,  2023 VS. 2028 (USD MILLION)
    FIGURE 16 MARKET: GEOGRAPHIC SNAPSHOT
 
4 PREMIUM INSIGHTS (Page No. - 68)
    4.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW 
          FIGURE 17 TECHNOLOGICAL ADVANCEMENTS AND INCREASED AUTOMATION TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: MARKET, BY PRODUCT AND COUNTRY 
          FIGURE 18 KITS DOMINATED NORTH AMERICAN NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS MARKET IN 2023
    4.3 MARKET SHARE,  BY TYPE, 2022 
          FIGURE 19 PLASMID DNA ISOLATION AND PURIFICATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
    4.4 MARKET SHARE,  BY PRODUCT, 2022 
          FIGURE 20 KITS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
    4.5 MARKET SHARE,  BY METHOD, 2022 
          FIGURE 21 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2022
    4.6 MARKET SHARE,  BY APPLICATION, 2022 
          FIGURE 22 DIAGNOSTICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
    4.7 MARKET SHARE,  BY END USER, 2022 
          FIGURE 23 HOSPITALS & DIAGNOSTIC CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
    4.8 GEOGRAPHICAL SNAPSHOT OF MARKET 
          FIGURE 24 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 73)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 25 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 4 MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing R&D activities
                    5.2.1.2 Technological advancements and increasing automation
                    5.2.1.3 Growing demand for molecular diagnostics
                                TABLE 5 ESTIMATED NUMBER OF NEW CANCER CASES GLOBALLY, BY TYPE OF CANCER,  2020 VS. 2025
                                TABLE 6 GLOBAL CANCER INCIDENCE, BY REGION, 2020 VS. 2025
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of automated instruments
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth opportunities in emerging economies
                    5.2.3.2 Improving regulatory and reimbursement scenario
                    5.2.3.3 Molecular diagnostics and personalized medicine
           5.2.4 CHALLENGES
                    5.2.4.1 Operational barriers and shortage of skilled professionals
                    5.2.4.2 Introduction of alternative technologies
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 26 REVENUE SHIFT & NEW REVENUE POCKETS FOR MARKET PROVIDERS
    5.4 PATENT ANALYSIS 
          FIGURE 27 MARKET: PATENT APPLICATIONS, OCTOBER 2013–OCTOBER 2023
          TABLE 7 MARKET: INDICATIVE LIST OF PATENTS
    5.5 VALUE CHAIN ANALYSIS 
          FIGURE 28 MARKET: VALUE CHAIN ANALYSIS
    5.6 SUPPLY CHAIN ANALYSIS 
          FIGURE 29 MARKET: SUPPLY CHAIN ANALYSIS
    5.7 ECOSYSTEM ANALYSIS 
          TABLE 8 MARKET: ECOSYSTEM ANALYSIS
    5.8 KEY CONFERENCES & EVENTS IN 2023–2024 
          TABLE 9 MARKET: DETAILED LIST OF CONFERENCES & EVENTS IN 2023–2024
    5.9 PRICING ANALYSIS 
           5.9.1 AVERAGE SELLING PRICE, BY PRODUCT
                    TABLE 10 AVERAGE SELLING PRICE OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS, 2022–2023 (USD)
           5.9.2 AVERAGE SELLING PRICE, BY REGION
                    TABLE 11 AVERAGE SELLING PRICE OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS, BY REGION, 2022–2023 (USD)
    5.10 TECHNOLOGY ANALYSIS 
    5.11 PORTER’S FIVE FORCES ANALYSIS 
           TABLE 12 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.11.1 THREAT OF NEW ENTRANTS
           5.11.2 THREAT OF SUBSTITUTES
           5.11.3 BARGAINING POWER OF SUPPLIERS
           5.11.4 BARGAINING POWER OF BUYERS
           5.11.5 INTENSITY OF COMPETITIVE RIVALRY
    5.12 REGULATORY ANALYSIS 
           5.12.1 REGULATORY BODIES
                     TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.13 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS
           5.13.2 BUYING CRITERIA FOR NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS
                     FIGURE 31 KEY BUYING CRITERIA FOR END USERS
 
6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,  BY PRODUCT (Page No. - 98)
    6.1 INTRODUCTION 
          TABLE 18 MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
    6.2 KITS 
           6.2.1 KITS TO ACCOUNT FOR LARGEST SHARE OF MARKET DURING FORECAST PERIOD
                    TABLE 19 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 20 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 21 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 22 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 23 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 24 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET,  BY REGION, 2021–2028 (USD MILLION)
    6.3 REAGENTS 
           6.3.1 AVAILABILITY OF READY-TO-USE REAGENTS TO DRIVE GROWTH
                    TABLE 25 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 26 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 27 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 28 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 29 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 30 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
    6.4 INSTRUMENTS 
          TABLE 31 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
          TABLE 32 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 33 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 34 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 35 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 36 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 37 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.4.1 AUTOMATIC INSTRUMENTS
                    6.4.1.1 Benefits of automatic instruments to drive growth
                                 TABLE 38 MARKET FOR AUTOMATIC INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)
                                 TABLE 39 NORTH AMERICA: MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 40 EUROPE: MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 41 ASIA PACIFIC: MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 42 LATIN AMERICA: MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 43 MIDDLE EAST & AFRICA: MARKET FOR AUTOMATIC INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)
           6.4.2 MANUAL INSTRUMENTS
                    6.4.2.1 Growing demand for nucleic acid isolation and purification in research and clinical applications to drive growth
                                 TABLE 44 MARKET FOR MANUAL INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)
                                 TABLE 45 NORTH AMERICA: MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 46 EUROPE: MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 47 ASIA PACIFIC: MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 48 LATIN AMERICA: MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 49 MIDDLE EAST & AFRICA: MARKET FOR MANUAL INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)
 
7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,  BY METHOD (Page No. - 117)
    7.1 INTRODUCTION 
          TABLE 50 MARKET, BY METHOD,  2021–2028 (USD MILLION)
    7.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION 
           7.2.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
                    TABLE 51 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 52 NORTH AMERICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 53 EUROPE: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 54 ASIA PACIFIC: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 55 LATIN AMERICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 56 MIDDLE EAST & AFRICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION)
    7.3 REAGENT-BASED ISOLATION AND PURIFICATION 
           7.3.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH DURING FORECAST PERIOD
                    TABLE 57 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 58 NORTH AMERICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 59 EUROPE: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 60 ASIA PACIFIC: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 61 LATIN AMERICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 62 MIDDLE EAST & AFRICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET,  BY REGION, 2021–2028 (USD MILLION)
    7.4 COLUMN-BASED ISOLATION AND PURIFICATION 
           7.4.1 GROWING POPULARITY OF COLUMN-BASED ISOLATION AND PURIFICATION IN CURRENT KITS TO BOOST MARKET
                    TABLE 63 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 64 NORTH AMERICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 65 EUROPE: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 66 ASIA PACIFIC: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 67 LATIN AMERICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 68 MIDDLE EAST & AFRICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET,  BY REGION, 2021–2028 (USD MILLION)
    7.5 OTHER ISOLATION AND PURIFICATION METHODS 
          TABLE 69 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION,  2021–2028 (USD MILLION)
          TABLE 70 NORTH AMERICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 71 EUROPE: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 72 ASIA PACIFIC: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 73 LATIN AMERICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 74 MIDDLE EAST & AFRICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET,  BY REGION, 2021–2028 (USD MILLION)
 
8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE (Page No. - 131)
    8.1 INTRODUCTION 
          TABLE 75 MARKET, BY TYPE,  2021–2028 (USD MILLION)
    8.2 PLASMID DNA ISOLATION AND PURIFICATION 
           8.2.1 PLASMID DNA ISOLATION AND PURIFICATION TO ACCOUNT FOR LARGEST SHARE OF MARKET
                    TABLE 76 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 77 NORTH AMERICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 78 EUROPE: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 79 ASIA PACIFIC: PLASMID DNA ISOLATION AND PURIFICATION MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 80 LATIN AMERICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 81 MIDDLE EAST & AFRICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET,  BY REGION, 2021–2028 (USD MILLION)
    8.3 TOTAL RNA ISOLATION AND PURIFICATION 
           8.3.1 WIDE USE OF TOTAL RNA ISOLATION AND PURIFICATION FOR RESEARCH AND DIAGNOSTIC APPLICATIONS TO BOOST MARKET
                    TABLE 82 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 83 NORTH AMERICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 84 EUROPE: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 85 ASIA PACIFIC: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 86 LATIN AMERICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 87 MIDDLE EAST & AFRICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET,  BY REGION, 2021–2028 (USD MILLION)
    8.4 GENOMIC DNA ISOLATION AND PURIFICATION 
           8.4.1 IMPORTANCE OF GENOMIC DNA ISOLATION IN GENETIC-BASED TESTS TO SUPPORT GROWTH
                    TABLE 88 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 89 NORTH AMERICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 90 EUROPE: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 91 ASIA PACIFIC: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 92 LATIN AMERICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 93 MIDDLE EAST & AFRICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET,  BY REGION, 2021–2028 (USD MILLION)
    8.5 MESSENGER RNA ISOLATION AND PURIFICATION 
           8.5.1 ROLE PLAYED BY MESSENGER RNA ISOLATION AND PURIFICATION IN GENE EXPRESSION AND TRANSCRIPTOMICS TO DRIVE GROWTH
                    TABLE 94 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 95 NORTH AMERICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 96 EUROPE: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 97 ASIA PACIFIC: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 98 LATIN AMERICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 99 MIDDLE EAST & AFRICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET,  BY REGION, 2021–2028 (USD MILLION)
    8.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION 
           8.6.1 ABILITY OF CIRCULATING NAIP TO ENABLE COLLECTION OF GENETIC INFORMATION FROM BODY FLUIDS TO BOOST ADOPTION
                    TABLE 100 MARKET, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 101 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 102 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 103 ASIA PACIFIC: MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 104 LATIN AMERICA: MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 105 MIDDLE EAST & AFRICA: MARKET, BY REGION, 2021–2028 (USD MILLION)
    8.7 MICRORNA ISOLATION AND PURIFICATION 
           8.7.1 GROWING APPLICATIONS OF MICRORNA ISOLATION AND PURIFICATION IN DRUG DEVELOPMENT RESEARCH TO FUEL GROWTH
                    TABLE 106 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 107 NORTH AMERICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 108 EUROPE: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 109 ASIA PACIFIC: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 110 LATIN AMERICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 111 MIDDLE EAST & AFRICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION)
    8.8 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES 
          TABLE 112 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION,  2021–2028 (USD MILLION)
          TABLE 113 NORTH AMERICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 114 EUROPE: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 115 ASIA PACIFIC: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 116 LATIN AMERICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 117 MIDDLE EAST & AFRICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2021–2028 (USD MILLION)
 
9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,  BY APPLICATION (Page No. - 154)
    9.1 INTRODUCTION 
          TABLE 118 MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
    9.2 DIAGNOSTICS 
           9.2.1 DIAGNOSTIC APPLICATIONS TO DOMINATE MARKET DURING FORECAST PERIOD
                    TABLE 119 MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 120 NORTH AMERICA: MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 121 EUROPE: MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 122 ASIA PACIFIC: MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 123 LATIN AMERICA: MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 124 MIDDLE EAST & AFRICA: MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
    9.3 DRUG DISCOVERY & DEVELOPMENT 
           9.3.1 POTENTIAL OF NAIP TO HELP IN DEVELOPMENT OF DRUGS FOR RARE DISEASES TO BOOST MARKET
                    TABLE 125 MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 126 NORTH AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 127 EUROPE: MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 128 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 129 LATIN AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 130 MIDDLE EAST & AFRICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION,  2021–2028 (USD MILLION)
    9.4 PERSONALIZED MEDICINE 
           9.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE GROWTH
                    TABLE 131 MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 132 NORTH AMERICA: MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 133 EUROPE: MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 134 ASIA PACIFIC: MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 135 LATIN AMERICA: MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 136 MIDDLE EAST & AFRICA: MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
    9.5 AGRICULTURE & ANIMAL RESEARCH 
           9.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH
                    TABLE 137 MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 138 NORTH AMERICA: MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 139 EUROPE: MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 140 ASIA PACIFIC: MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 141 LATIN AMERICA: MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 142 MIDDLE EAST & AFRICA: MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY REGION,  2021–2028 (USD MILLION)
    9.6 OTHER APPLICATIONS 
          TABLE 143 MARKET FOR OTHER APPLICATIONS,  BY REGION, 2021–2028 (USD MILLION)
          TABLE 144 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 145 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 146 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 147 LATIN AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 148 MIDDLE EAST & AFRICA: MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
 
10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,  BY END USER (Page No. - 173)
     10.1 INTRODUCTION 
             TABLE 149 MARKET, BY END USER,  2021–2028 (USD MILLION)
     10.2 HOSPITALS & DIAGNOSTIC CENTERS 
             10.2.1 RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH
                        TABLE 150 MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 151 NORTH AMERICA: MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 152 EUROPE: MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 153 ASIA PACIFIC: MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 154 LATIN AMERICA: MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 155 MIDDLE EAST & AFRICA: MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)
     10.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 
             10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS
                        TABLE 156 MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 157 NORTH AMERICA: MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 158 EUROPE: MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 159 ASIA PACIFIC: MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 160 LATIN AMERICA: MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 161 MIDDLE EAST & AFRICA: MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION,  2021–2028 (USD MILLION)
     10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
             10.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS TO DRIVE SEGMENT GROWTH
                        TABLE 162 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 163 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,  2021–2028 (USD MILLION)
                        TABLE 164 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 165 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,  2021–2028 (USD MILLION)
                        TABLE 166 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,  2021–2028 (USD MILLION)
                        TABLE 167 MIDDLE EAST & AFRICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,  2021–2028 (USD MILLION)
     10.5 CONTRACT RESEARCH ORGANIZATIONS 
             10.5.1 CONTRACT RESEARCH ORGANIZATIONS TO REGISTER STEADY GROWTH DURING FORECAST PERIOD
                        TABLE 168 MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 169 NORTH AMERICA: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 170 EUROPE: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 171 ASIA PACIFIC: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 172 LATIN AMERICA: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 173 MIDDLE EAST & AFRICA: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION)
     10.6 OTHER END USERS 
             TABLE 174 MARKET FOR OTHER END USERS,  BY REGION, 2021–2028 (USD MILLION)
             TABLE 175 NORTH AMERICA: MARKET FOR OTHER  END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 176 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 177 ASIA PACIFIC: MARKET FOR OTHER  END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 178 LATIN AMERICA: MARKET FOR OTHER  END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 179 MIDDLE EAST & AFRICA: MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
 
11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION (Page No. - 193)
     11.1 INTRODUCTION 
             TABLE 180 MARKET, BY REGION,  2021–2028 (USD MILLION)
     11.2 NORTH AMERICA 
             FIGURE 32 NORTH AMERICA: MARKET SNAPSHOT
             TABLE 181 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 182 NORTH AMERICA: MARKET, BY METHOD, 2021–2028 (USD MILLION)
             TABLE 183 NORTH AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 184 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 185 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 186 NORTH AMERICA: MARKET,  BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 187 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.1 US
                        11.2.1.1 Government and private funding to support market growth
                                      TABLE 188 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD,  2021–2028 (USD MILLION)
                                      TABLE 189 US: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 190 US: MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
                                      TABLE 191 US: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 192 US: MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 193 US: MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.2.2 CANADA
                        11.2.2.1 Growing investments in genomics to boost market demand
                                      TABLE 194 CANADA: MARKET, BY METHOD,  2021–2028 (USD MILLION)
                                      TABLE 195 CANADA: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 196 CANADA: MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
                                      TABLE 197 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 198 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 199 CANADA: MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.2.3 NORTH AMERICA: RECESSION IMPACT
     11.3 EUROPE 
             TABLE 200 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
             TABLE 201 EUROPE: MARKET, BY METHOD,  2021–2028 (USD MILLION)
             TABLE 202 EUROPE: MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 203 EUROPE: MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
             TABLE 204 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
             TABLE 205 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 206 EUROPE: MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.3.1 GERMANY
                        11.3.1.1 Germany to dominate market in Europe
                                      TABLE 207 CANCER INCIDENCE IN GERMANY, BY TYPE, 2020 VS. 2027
                                      TABLE 208 GERMANY: MARKET, BY METHOD,  2021–2028 (USD MILLION)
                                      TABLE 209 GERMANY: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 210 GERMANY: MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
                                      TABLE 211 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 212 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 213 GERMANY: MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.3.2 UK
                        11.3.2.1 Government support for research through investments, funds, and grants to support market growth
                                      TABLE 214 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD,  2021–2028 (USD MILLION)
                                      TABLE 215 UK: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 216 UK: MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
                                      TABLE 217 UK: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 218 UK: MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 219 UK: MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 High cancer burden to drive market growth
                                      TABLE 220 FRANCE: MARKET, BY METHOD,  2021–2028 (USD MILLION)
                                      TABLE 221 FRANCE: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 222 FRANCE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 223 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 224 FRANCE: MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 225 FRANCE: MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.3.4 ITALY
                        11.3.4.1 Government support to drive market growth in Italy
                                      TABLE 226 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD,  2021–2028 (USD MILLION)
                                      TABLE 227 ITALY: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 228 ITALY: MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
                                      TABLE 229 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 230 ITALY: MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 231 ITALY: MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.3.5 SPAIN
                        11.3.5.1 High adoption of advanced diagnostic technologies to drive market growth in Spain
                                      TABLE 232 SPAIN: MARKET, BY METHOD,  2021–2028 (USD MILLION)
                                      TABLE 233 SPAIN: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 234 SPAIN: MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
                                      TABLE 235 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 236 SPAIN: MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 237 SPAIN: MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.3.6 REST OF EUROPE
                        TABLE 238 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
                        TABLE 239 REST OF EUROPE MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 240 REST OF EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 241 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 242 REST OF EUROPE: MARKET,  BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 243 REST OF EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.7 EUROPE: RECESSION IMPACT
     11.4 ASIA PACIFIC 
             FIGURE 33 ASIA PACIFIC: MARKET SNAPSHOT
             TABLE 244 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 245 ASIA PACIFIC: MARKET, BY METHOD, 2021–2028 (USD MILLION)
             TABLE 246 ASIA PACIFIC: MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 247 ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 248 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
             TABLE 249 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 250 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.1 CHINA
                        11.4.1.1 China to register highest growth in nucleic acid isolation and purification market in Asia Pacific region
                                      TABLE 251 CHINA: MARKET, BY METHOD,  2021–2028 (USD MILLION)
                                      TABLE 252 CHINA: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 253 CHINA: MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
                                      TABLE 254 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 255 CHINA: MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 256 CHINA: MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.4.2 JAPAN
                        11.4.2.1 Growing number of conferences & workshops to drive market growth
                                      TABLE 257 JAPAN: MARKET, BY METHOD,  2021–2028 (USD MILLION)
                                      TABLE 258 JAPAN: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 259 JAPAN: MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
                                      TABLE 260 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 261 JAPAN: MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 262 JAPAN: MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.4.3 INDIA
                        11.4.3.1 Focused initiatives in pharmaceutical & biotechnology industries to drive market growth
                                      TABLE 263 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD,  2021–2028 (USD MILLION)
                                      TABLE 264 INDIA: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 265 INDIA: MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
                                      TABLE 266 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 267 INDIA: MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 268 INDIA: MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.4.4 SOUTH KOREA
                        11.4.4.1 Support from governments to drive market in region
                                      TABLE 269 SOUTH KOREA: MARKET, BY METHOD, 2021–2028 (USD MILLION)
                                      TABLE 270 SOUTH KOREA: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 271 SOUTH KOREA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 272 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 273 SOUTH KOREA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 274 SOUTH KOREA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.5 REST OF ASIA PACIFIC (ROAPAC)
                        TABLE 275 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET,  BY METHOD, 2021–2028 (USD MILLION)
                        TABLE 276 REST OF ASIA PACIFIC: MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 277 REST OF ASIA PACIFIC: MARKET,  BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 278 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 279 REST OF ASIA PACIFIC: MARKET,  BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 280 REST OF ASIA PACIFIC: MARKET,  BY END USER, 2021–2028 (USD MILLION)
             11.4.6 ASIA PACIFIC: RECESSION IMPACT
     11.5 LATIN AMERICA 
             TABLE 281 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 282 LATIN AMERICA: MARKET, BY METHOD, 2021–2028 (USD MILLION)
             TABLE 283 LATIN AMERICA: MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 284 LATIN AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 285 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 286 LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 287 LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.5.1 BRAZIL
                        11.5.1.1 Brazil to dominate LATAM market
                                      TABLE 288 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD,  2021–2028 (USD MILLION)
                                      TABLE 289 BRAZIL: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 290 BRAZIL: MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
                                      TABLE 291 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 292 BRAZIL: MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 293 BRAZIL: MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.5.2 MEXICO
                        11.5.2.1 Favorable trade agreements to support imports and improve access to NAIP instruments in Mexico
                                      TABLE 294 MEXICO: MARKET, BY METHOD,  2021–2028 (USD MILLION)
                                      TABLE 295 MEXICO: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 296 MEXICO: MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
                                      TABLE 297 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 298 MEXICO: MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 299 MEXICO: MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.5.3 REST OF LATIN AMERICA
                        TABLE 300 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
                        TABLE 301 REST OF LATIN AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 302 REST OF LATIN AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 303 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 304 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 305 REST OF LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.5.4 LATIN AMERICA: RECESSION IMPACT
     11.6 MIDDLE EAST & AFRICA 
             TABLE 306 MIDDLE EAST & AFRICA: MARKET,  BY REGION, 2021–2028 (USD MILLION)
             TABLE 307 MIDDLE EAST & AFRICA: MARKET,  BY METHOD, 2021–2028 (USD MILLION)
             TABLE 308 MIDDLE EAST & AFRICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 309 MIDDLE EAST & AFRICA: MARKET,  BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 310 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 311 MIDDLE EAST & AFRICA: MARKET,  BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 312 MIDDLE EAST & AFRICA: MARKET,  BY END USER, 2021–2028 (USD MILLION)
             11.6.1 MIDDLE EAST
                        11.6.1.1 Growing focus on molecular diagnostics and research to drive market
                                      TABLE 313 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
                                      TABLE 314 MIDDLE EAST: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 315 MIDDLE EAST: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 316 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 317 MIDDLE EAST: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 318 MIDDLE EAST: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.6.2 AFRICA
                        11.6.2.1 Government support for research studies to fuel growth
                                      TABLE 319 AFRICA: MARKET, BY METHOD,  2021–2028 (USD MILLION)
                                      TABLE 320 AFRICA: MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 321 AFRICA: MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
                                      TABLE 322 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 323 AFRICA: MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                                      TABLE 324 AFRICA: MARKET, BY END USER,  2021–2028 (USD MILLION) 
             11.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT
 
12 COMPETITIVE LANDSCAPE (Page No. - 275)
     12.1 INTRODUCTION 
     12.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 
             TABLE 325 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: STRATEGIES ADOPTED
     12.3 REVENUE ANALYSIS 
             FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS (2018–2022)
     12.4 MARKET SHARE ANALYSIS 
             FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
             TABLE 326 MARKET: DEGREE OF COMPETITION
     12.5 COMPANY EVALUATION MATRIX 
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                       FIGURE 36 COMPANY EVALUATION MATRIX, 2022
             12.5.5 COMPANY FOOTPRINT ANALYSIS
                        12.5.5.1 Company footprint
                                      TABLE 327 COMPANY FOOTPRINT ANALYSIS: KEY PLAYERS
                        12.5.5.2 Company product footprint
                                      TABLE 328 MARKET: PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
                        12.5.5.3 Company regional footprint
                                      TABLE 329 MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
     12.6 START-UP/SME EVALUATION MATRIX 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 RESPONSIVE COMPANIES
             12.6.3 DYNAMIC COMPANIES
             12.6.4 STARTING BLOCKS
                        FIGURE 37 START-UP/SME EVALUATION MATRIX, 2022
             12.6.5 COMPETITIVE BENCHMARKING
                        TABLE 330 MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
                        TABLE 331 MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
     12.7 COMPETITIVE SCENARIO AND TRENDS 
             12.7.1 PRODUCT LAUNCHES
                        TABLE 332 MARKET: PRODUCT LAUNCHES, JANUARY 2020–OCTOBER 2023
             12.7.2 DEALS
                        TABLE 333 MARKET: DEALS, JANUARY 2020 TO OCTOBER 2023
             12.7.3 OTHER DEVELOPMENTS
                        TABLE 334 MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO OCTOBER 2023
 
13 COMPANY PROFILES (Page No. - 294)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     13.1 MAJOR PLAYERS 
             13.1.1 THERMO FISHER SCIENTIFIC INC.
                        TABLE 335 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
                        FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
             13.1.2 QIAGEN
                        TABLE 336 QIAGEN: BUSINESS OVERVIEW
                        FIGURE 39 QIAGEN: COMPANY SNAPSHOT (2022)
             13.1.3 F. HOFFMANN-LA ROCHE LTD.
                        TABLE 337 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
                        FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
             13.1.4 MERCK KGAA
                        TABLE 338 MERCK KGAA: BUSINESS OVERVIEW
                        FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022)
             13.1.5 PROMEGA CORPORATION
                        TABLE 339 PROMEGA CORPORATION: BUSINESS OVERVIEW
             13.1.6 AGILENT TECHNOLOGIES, INC.
                        TABLE 340 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
                        FIGURE 42 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
             13.1.7 DANAHER
                        TABLE 341 DANAHER: BUSINESS OVERVIEW
                        FIGURE 43 DANAHER: COMPANY SNAPSHOT (2022)
             13.1.8 BIO-RAD LABORATORIES, INC.
                        TABLE 342 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
                        FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
             13.1.9 ILLUMINA, INC.
                        TABLE 343 ILLUMINA, INC.: BUSINESS OVERVIEW
                        FIGURE 45 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
             13.1.10 TAKARA BIO INC.
                        TABLE 344 TAKARA BIO INC.: BUSINESS OVERVIEW
                        FIGURE 46 TAKARA BIO INC.: COMPANY SNAPSHOT (2022)
             13.1.11 NEW ENGLAND BIOLABS
                        TABLE 345 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
             13.1.12 ABCAM PLC
                        TABLE 346 ABCAM PLC: BUSINESS OVERVIEW
                        FIGURE 47 ABCAM PLC: COMPANY SNAPSHOT (2022)
     13.2 OTHER COMPANIES 
             13.2.1 KILPEST INDIA LIMITED
                        TABLE 347 KILPEST INDIA LIMITED: COMPANY OVERVIEW
             13.2.2 APICAL SCIENTIFIC SDN. BHD.
                        TABLE 348 APICAL SCIENTIFIC SDN. BHD.: COMPANY OVERVIEW
             13.2.3 ENDRESS+HAUSER GROUP SERVICES AG
                        TABLE 349 ENDRESS+HAUSER GROUP SERVICES AG: COMPANY OVERVIEW
             13.2.4 GENAXXON BIOSCIENCE GMBH
                        TABLE 350 GENAXXON BIOSCIENCE GMBH: COMPANY OVERVIEW
             13.2.5 LGC BIOSEARCH TECHNOLOGIES
                        TABLE 351 LGC BIOSEARCH TECHNOLOGIES: COMPANY OVERVIEW
             13.2.6 ZYMO RESEARCH CORPORATION
                        TABLE 352 ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW
             13.2.7 NORGEN BIOTEK CORP.
                        TABLE 353 NORGEN BIOTEK CORP.: COMPANY OVERVIEW
             13.2.8 OMEGA BIO-TEK, INC.
                        TABLE 354 OMEGA BIO-TEK, INC.: COMPANY OVERVIEW
             13.2.9 FAVORGEN BIOTECH CORPORATION
                        TABLE 355 FAVORGEN BIOTECH CORPORATION: COMPANY OVERVIEW
             13.2.10 TIANGEN BIOTECH(BEIJING)CO., LTD.
                        TABLE 356 TIANGEN BIOTECH(BEIJING)CO., LTD.: COMPANY OVERVIEW
             13.2.11 AUTOGEN INC.
                        TABLE 357 AUTOGEN INC.: COMPANY OVERVIEW
             13.2.12 PCR BIOSYSTEMS
                        TABLE 358 PCR BIOSYSTEMS: COMPANY OVERVIEW
             13.2.13 BIOGENUIX
                        TABLE 359 BIOGENUIX: COMPANY OVERVIEW
 
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 381)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global nucleic acid isolation and purification market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred for this research study include publications from government sources such as the World Health Organization (WHO), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), European Society of Human Genetics (ESHG), University Hospitals Southampton NHS Foundation Trust, Genomics England, Scottish Genome Partnership, Berlin Institute of Health, Max Delbrück Center for Molecular Medicine, and European Federation of Biotechnology (EFB). Company Websites, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets Analysis. Secondary data was collected and analyzed to arrive at the overall size of the global market, which was then validated by primary research.

Primary Research

Primary research was conducted to validate the market segmentation, identify key players, and gather insights into key industry trends and market dynamics.

Extensive primary research was conducted after acquiring basic knowledge about the global market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side (hospitals and diagnostics centers, academic institutes and government organizations, pharmaceutical and biotechnology companies, and others) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, from Tier 1 and Tier 2 companies engaged in offering products) across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. The primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Nucleic Acid Isolation and Purification  Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The report presents a detailed assessment of the nucleic acid isolation and purification market and qualitative inputs and insights from MarketsandMarkets. The total market size was determined after data triangulation from three different approaches. After completing each approach, the weighted average of the three approaches was taken based on each approach’s level of assumptions. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • From the list of manufacturers in the market, companies were identified and finalized from secondary research.
  • Revenues for individual companies were gathered from public sources and databases.
  • The business shares of leading players were gathered from secondary sources to the extent available. In certain cases, the shares of product businesses were ascertained through a detailed analysis of various parameters, including product portfolios and market positioning.
  • Individual shares or revenue estimates were validated through expert interviews.

Top-Down Approach

Nucleic Acid Isolation and Purification  Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Approach: MnM Repository Analysis

For the estimation of the nucleic acid isolation and purification market, related market reports in the MnM repository were considered. the global and regional market values of nucleic acid isolation and purification and dependent submarkets were extracted from the MnM repository and validated through secondary and primary research. the final global market size was triangulated through the average of all approaches and validated through primary interviews with industry experts.

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition:

Nucleic acid isolation and purification is a set of molecular biology techniques used for the extraction of DNA and RNA for use in downstream applications, such as sequencing, cloning, and polymerase chain reaction. These downstream applications are important parts of life science research, molecular diagnostics, forensics, and genetic engineering.

Key Stakeholders

  • Manufacturers and vendors of nucleic acid isolation and purification kits and instruments
  • Research associations related to genomics
  • Hospitals & diagnostic centers
  • Contract research organizations
  • Healthcare institutions
  • Research institutes
  • Pharmaceutical & biotechnology companies
  • Government & academic institutes
  • Community centers

Report Objectives

  • To define, describe, and forecast the nucleic acid isolation and purification market by product, method, type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micro markets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations, in the global market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographical Analysis

  • Further breakdown of the RoE market, by country
  • Further breakdown of the RoAPAC market, by country
  • Further breakdown of the RoLATAM market, by country
Company Information
  • Detailed analysis and profiling of additional market players (Up to five)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 2398
Published ON
Oct, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Nucleic Acid Isolation and Purification Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback